the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer

Exclusion Criteria

• •1. Recurrent or distant metastatic disease;
• •2. Prior malignancies (other than curable non-melanoma skin cancer) within 5 years;
• •3. Active autoimmune diseases requiring systemic treatment or other diseases requiring long-term use of substantial amount of hormones or other immunosuppressants;
• •4. Patients who need to receive systemic corticosteroids (dose equivalent to or higher than prednisone 10mg qd) or other immunosuppressants within 14 days before enrollment or during the study;
• •5. Vaccination of live attenuated vaccine 30 days before enrollment, or planned vaccination of live attenuated vaccine during the study;
• •6. Previous organ transplantation or HIV patients;
• •7. Allergic to macromolecular proteins /monoclonal antibodies, or to any test drug component;
• •8. Active acute or chronic viral hepatitis B or C. Hepatitis B virus (HBV) DNA\> 2000IU/ml or 104 copies/ml; hepatitis C virus (HCV) RNA\> 103 copies/ml.